Tissue magnesium levels and the arrhythmic substrate in humans

Mark C.P. Haigney, Ronald Berger, Steven Schulman, Gary Gerstenblith, Carol Tunin, Burton Silver, Howard S. Silverman, Gordon F. Tomaselli, Hugh Calkins

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Introduction: Magnesium deficiency has been implicated in the pathogenesis of sudden death, but the investigation of arrhythmic mechanisms has been hindered by difficulties in measuring cellular tissue magnesium stores. Methods and Results: To see if magnesium deficiency is associated with a propensity toward triggered arrhythmias, we measured tissue magnesium levels and QT interval dispersion (as an index of repolarization dispersion) in 40 patients with arrhythmic complaints. Magnesium was measured in sublingual epithelium using X-ray dispersive analysis. QT interval dispersion was assessed on 12-lead surface ECGs in all patients, and programmed stimulation was performed in 28. The sublingual epithelial magnesium level ([Mg](i)), but the not the serum level, correlated inversely with QT interval dispersion in 40 patients (r = 0.58, P < 0.005); in 12 patients undergoing repeat testing on therapy, the change in magnesium also correlated inversely with the change in QT dispersion (r = 0.61, P < 0.05). Patients with left ventricular ejection fractions > 40% had significantly higher tissue magnesium and lower QT dispersion (34.5 ± 0.5 mEq/L, 81 ± 8 msec) than those with left ventricular ejection, fractions < 40% (32.7 ± 0.5 mEq/L, P < 0.01, and 114 ± 9 msec, P < 0.05). There was no difference in either [Mg](i) or QT dispersion in the 16 patients with inducible monomorphic ventricular tachycardia versus the 12 noninducible patients. Conclusion: Reduced tissue magnesium stores may represent a significant risk factor for arrhythmias associated with abnormal repolarization, particularly in patients with poor left ventricular systolic function, but may not represent a risk for excitable gap arrhythmias associated with a fixed anatomic substrate (e.g., monomorphic ventricular tachycardia).

Original languageEnglish (US)
Pages (from-to)980-986
Number of pages7
JournalJournal of Cardiovascular Electrophysiology
Volume8
Issue number9
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Magnesium
Magnesium Deficiency
Cardiac Arrhythmias
Ventricular Tachycardia
Sudden Death
Left Ventricular Function
Stroke Volume
Electrocardiography
Epithelium
X-Rays
Serum

Keywords

  • Heart failure
  • Magnesium
  • QT interval
  • Reentry

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Haigney, M. C. P., Berger, R., Schulman, S., Gerstenblith, G., Tunin, C., Silver, B., ... Calkins, H. (1997). Tissue magnesium levels and the arrhythmic substrate in humans. Journal of Cardiovascular Electrophysiology, 8(9), 980-986. https://doi.org/10.1111/j.1540-8167.1997.tb00620.x

Tissue magnesium levels and the arrhythmic substrate in humans. / Haigney, Mark C.P.; Berger, Ronald; Schulman, Steven; Gerstenblith, Gary; Tunin, Carol; Silver, Burton; Silverman, Howard S.; Tomaselli, Gordon F.; Calkins, Hugh.

In: Journal of Cardiovascular Electrophysiology, Vol. 8, No. 9, 01.01.1997, p. 980-986.

Research output: Contribution to journalArticle

Haigney, MCP, Berger, R, Schulman, S, Gerstenblith, G, Tunin, C, Silver, B, Silverman, HS, Tomaselli, GF & Calkins, H 1997, 'Tissue magnesium levels and the arrhythmic substrate in humans', Journal of Cardiovascular Electrophysiology, vol. 8, no. 9, pp. 980-986. https://doi.org/10.1111/j.1540-8167.1997.tb00620.x
Haigney MCP, Berger R, Schulman S, Gerstenblith G, Tunin C, Silver B et al. Tissue magnesium levels and the arrhythmic substrate in humans. Journal of Cardiovascular Electrophysiology. 1997 Jan 1;8(9):980-986. https://doi.org/10.1111/j.1540-8167.1997.tb00620.x
Haigney, Mark C.P. ; Berger, Ronald ; Schulman, Steven ; Gerstenblith, Gary ; Tunin, Carol ; Silver, Burton ; Silverman, Howard S. ; Tomaselli, Gordon F. ; Calkins, Hugh. / Tissue magnesium levels and the arrhythmic substrate in humans. In: Journal of Cardiovascular Electrophysiology. 1997 ; Vol. 8, No. 9. pp. 980-986.
@article{a05c969fb8994198b93b7b3be4d9389b,
title = "Tissue magnesium levels and the arrhythmic substrate in humans",
abstract = "Introduction: Magnesium deficiency has been implicated in the pathogenesis of sudden death, but the investigation of arrhythmic mechanisms has been hindered by difficulties in measuring cellular tissue magnesium stores. Methods and Results: To see if magnesium deficiency is associated with a propensity toward triggered arrhythmias, we measured tissue magnesium levels and QT interval dispersion (as an index of repolarization dispersion) in 40 patients with arrhythmic complaints. Magnesium was measured in sublingual epithelium using X-ray dispersive analysis. QT interval dispersion was assessed on 12-lead surface ECGs in all patients, and programmed stimulation was performed in 28. The sublingual epithelial magnesium level ([Mg](i)), but the not the serum level, correlated inversely with QT interval dispersion in 40 patients (r = 0.58, P < 0.005); in 12 patients undergoing repeat testing on therapy, the change in magnesium also correlated inversely with the change in QT dispersion (r = 0.61, P < 0.05). Patients with left ventricular ejection fractions > 40{\%} had significantly higher tissue magnesium and lower QT dispersion (34.5 ± 0.5 mEq/L, 81 ± 8 msec) than those with left ventricular ejection, fractions < 40{\%} (32.7 ± 0.5 mEq/L, P < 0.01, and 114 ± 9 msec, P < 0.05). There was no difference in either [Mg](i) or QT dispersion in the 16 patients with inducible monomorphic ventricular tachycardia versus the 12 noninducible patients. Conclusion: Reduced tissue magnesium stores may represent a significant risk factor for arrhythmias associated with abnormal repolarization, particularly in patients with poor left ventricular systolic function, but may not represent a risk for excitable gap arrhythmias associated with a fixed anatomic substrate (e.g., monomorphic ventricular tachycardia).",
keywords = "Heart failure, Magnesium, QT interval, Reentry",
author = "Haigney, {Mark C.P.} and Ronald Berger and Steven Schulman and Gary Gerstenblith and Carol Tunin and Burton Silver and Silverman, {Howard S.} and Tomaselli, {Gordon F.} and Hugh Calkins",
year = "1997",
month = "1",
day = "1",
doi = "10.1111/j.1540-8167.1997.tb00620.x",
language = "English (US)",
volume = "8",
pages = "980--986",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Tissue magnesium levels and the arrhythmic substrate in humans

AU - Haigney, Mark C.P.

AU - Berger, Ronald

AU - Schulman, Steven

AU - Gerstenblith, Gary

AU - Tunin, Carol

AU - Silver, Burton

AU - Silverman, Howard S.

AU - Tomaselli, Gordon F.

AU - Calkins, Hugh

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Introduction: Magnesium deficiency has been implicated in the pathogenesis of sudden death, but the investigation of arrhythmic mechanisms has been hindered by difficulties in measuring cellular tissue magnesium stores. Methods and Results: To see if magnesium deficiency is associated with a propensity toward triggered arrhythmias, we measured tissue magnesium levels and QT interval dispersion (as an index of repolarization dispersion) in 40 patients with arrhythmic complaints. Magnesium was measured in sublingual epithelium using X-ray dispersive analysis. QT interval dispersion was assessed on 12-lead surface ECGs in all patients, and programmed stimulation was performed in 28. The sublingual epithelial magnesium level ([Mg](i)), but the not the serum level, correlated inversely with QT interval dispersion in 40 patients (r = 0.58, P < 0.005); in 12 patients undergoing repeat testing on therapy, the change in magnesium also correlated inversely with the change in QT dispersion (r = 0.61, P < 0.05). Patients with left ventricular ejection fractions > 40% had significantly higher tissue magnesium and lower QT dispersion (34.5 ± 0.5 mEq/L, 81 ± 8 msec) than those with left ventricular ejection, fractions < 40% (32.7 ± 0.5 mEq/L, P < 0.01, and 114 ± 9 msec, P < 0.05). There was no difference in either [Mg](i) or QT dispersion in the 16 patients with inducible monomorphic ventricular tachycardia versus the 12 noninducible patients. Conclusion: Reduced tissue magnesium stores may represent a significant risk factor for arrhythmias associated with abnormal repolarization, particularly in patients with poor left ventricular systolic function, but may not represent a risk for excitable gap arrhythmias associated with a fixed anatomic substrate (e.g., monomorphic ventricular tachycardia).

AB - Introduction: Magnesium deficiency has been implicated in the pathogenesis of sudden death, but the investigation of arrhythmic mechanisms has been hindered by difficulties in measuring cellular tissue magnesium stores. Methods and Results: To see if magnesium deficiency is associated with a propensity toward triggered arrhythmias, we measured tissue magnesium levels and QT interval dispersion (as an index of repolarization dispersion) in 40 patients with arrhythmic complaints. Magnesium was measured in sublingual epithelium using X-ray dispersive analysis. QT interval dispersion was assessed on 12-lead surface ECGs in all patients, and programmed stimulation was performed in 28. The sublingual epithelial magnesium level ([Mg](i)), but the not the serum level, correlated inversely with QT interval dispersion in 40 patients (r = 0.58, P < 0.005); in 12 patients undergoing repeat testing on therapy, the change in magnesium also correlated inversely with the change in QT dispersion (r = 0.61, P < 0.05). Patients with left ventricular ejection fractions > 40% had significantly higher tissue magnesium and lower QT dispersion (34.5 ± 0.5 mEq/L, 81 ± 8 msec) than those with left ventricular ejection, fractions < 40% (32.7 ± 0.5 mEq/L, P < 0.01, and 114 ± 9 msec, P < 0.05). There was no difference in either [Mg](i) or QT dispersion in the 16 patients with inducible monomorphic ventricular tachycardia versus the 12 noninducible patients. Conclusion: Reduced tissue magnesium stores may represent a significant risk factor for arrhythmias associated with abnormal repolarization, particularly in patients with poor left ventricular systolic function, but may not represent a risk for excitable gap arrhythmias associated with a fixed anatomic substrate (e.g., monomorphic ventricular tachycardia).

KW - Heart failure

KW - Magnesium

KW - QT interval

KW - Reentry

UR - http://www.scopus.com/inward/record.url?scp=0030931694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030931694&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.1997.tb00620.x

DO - 10.1111/j.1540-8167.1997.tb00620.x

M3 - Article

VL - 8

SP - 980

EP - 986

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 9

ER -